1. Phase IIa/IIb clinical trial of NC-6004 (Nanoparticle Cisplatin) plus Pembrolizumab in patients with head and neck cancer (HNSCC) who have failed platinum or a platinum-containing regimen. (October 2020) Authors: Osada, A.; Mangel, L.; Fijuth, J.; Żurawski, B.; Ursulovic, T.; Nikolin, B.; Djan, I.; Olson, J. Grilley Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-083 Analysis of received doses at organs of risk in SCCHN patients treated with postoperative VMAT-SIB. (March 2019) Authors: Djan, I.; Petrovic, B.; Rutonjski, L.; Nikolin, B.; Jović, R. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗